机构:[1]Research Center of Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China[2]Department of Biochemistry, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China[3]The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510006, China广东省中医院[4]College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China[5]State Key Laboratory of New-Tech for Chinese Medicine Pharmaceutical Process, Lianyungang 222001, China
Reduning Injection (RDNI) is a traditional Chinese medicine formula indicated for the treatment of inflammatory diseases. However, the molecular mechanism of RDNI is unclear. The information of RDNI ingredients was collected from previous studies. Targets of them were obtained by data mining and molecular docking. The information of targets and related pathways was collected in UniProt and KEGG. Networks were constructed and analyzed by Cytoscape to identify key compounds, targets, and pathways. Data mining and molecular docking identified 11 compounds, 84 targets, and 201 pathways that are related to the anti-inflammatory activity of RDNI. Network analysis identified two key compounds (caffeic acid and ferulic acid), five key targets (Bcl-2, eNOS, PTGS2, PPARA, and MMPs), and four key pathways (estrogen signaling pathway, PI3K-AKT signaling pathway, cGMP-PKG signaling pathway, and calcium signaling pathway) which would play critical roles in the treatment of inflammatory diseases by RDNI. The cross-talks among pathways provided a deeper understanding of anti-inflammatory effect of RDNI. RDNI is capable of regulating multiple biological processes and treating inflammation at a systems level. Network pharmacology is a practical approach to explore the therapeutic mechanism of TCM for complex disease.
基金:
start-up support for scientific research of Xinglin Young Scholar in Guangzhou University of Chinese Medicine [A1-AFD018161Z04]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81904198, 81804111]; Guangdong Provincial Hospital of Traditional Chinese Medicine Science and Technology Research Program [YN2016MJ06]
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类|3 区生物
小类|3 区生物工程与应用微生物4 区医学:研究与实验
最新[2025]版:
大类|4 区医学
小类|4 区生物工程与应用微生物4 区医学:研究与实验
JCR分区:
出版当年[2018]版:
Q3MEDICINE, RESEARCH & EXPERIMENTALQ3BIOTECHNOLOGY & APPLIED MICROBIOLOGY
最新[2023]版:
Q3BIOTECHNOLOGY & APPLIED MICROBIOLOGYQ3MEDICINE, RESEARCH & EXPERIMENTAL
第一作者机构:[1]Research Center of Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China[2]Department of Biochemistry, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
通讯作者:
通讯机构:[1]Research Center of Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China[2]Department of Biochemistry, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
推荐引用方式(GB/T 7714):
Xie Fuda,Xie Mingxiang,Yang Yibing,et al.Assessing the Anti-inflammatory Mechanism of Reduning Injection by Network Pharmacology[J].BIOMED RESEARCH INTERNATIONAL.2020,2020:doi:10.1155/2020/6134098.
APA:
Xie, Fuda,Xie, Mingxiang,Yang, Yibing,Zhang, Miaomiao,Xu, Xiaojie...&Gu, Jiangyong.(2020).Assessing the Anti-inflammatory Mechanism of Reduning Injection by Network Pharmacology.BIOMED RESEARCH INTERNATIONAL,2020,
MLA:
Xie, Fuda,et al."Assessing the Anti-inflammatory Mechanism of Reduning Injection by Network Pharmacology".BIOMED RESEARCH INTERNATIONAL 2020.(2020)